Weaver Consulting Group’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.27M | Sell |
5,013
-36
| -0.7% | -$8.39K | 0.26% | 81 |
|
|
2026
Q1 | $1.23M | Sell |
5,049
-61
| -1% | -$14.2K | 0.29% | 75 |
|
|
2025
Q4 | $1.06M | Sell |
5,110
-29
| -0.6% | -$5.74K | 0.26% | 80 |
|
|
2025
Q3 | $953K | Sell |
5,139
-49
| -0.9% | -$8.39K | 0.24% | 84 |
|
|
2025
Q2 | $792K | Sell |
5,188
-56
| -1% | -$8.61K | 0.22% | 87 |
|
|
2025
Q1 | $870K | Sell |
5,244
-166
| -3% | -$26K | 0.26% | 74 |
|
|
2024
Q4 | $782K | Sell |
5,410
-149
| -3% | -$23.1K | 0.24% | 79 |
|
|
2024
Q3 | $901K | Buy |
5,559
+4
| +0.1% | +$637 | 0.29% | 73 |
|
|
2024
Q2 | $812K | Buy |
5,555
+28
| +0.5% | +$4.16K | 0.28% | 75 |
|
|
2024
Q1 | $874K | Sell |
5,527
-16
| -0.3% | -$2.55K | 0.32% | 68 |
|
|
2023
Q4 | $869K | Buy |
5,543
+39
| +0.7% | +$5.98K | 0.35% | 57 |
|
|
2023
Q3 | $857K | Sell |
5,504
-43
| -0.8% | -$7.09K | 0.39% | 56 |
|
|
2023
Q2 | $918K | Buy |
5,547
+9
| +0.2% | +$1.45K | 0.41% | 53 |
|
|
2023
Q1 | $858K | Buy |
5,538
+446
| +9% | +$72K | 0.39% | 53 |
|
|
2022
Q4 | $900K | Sell |
5,092
-539
| -10% | -$93.1K | 0.46% | 46 |
|
|
2022
Q3 | $920K | Sell |
5,631
-222
| -4% | -$37.6K | 0.53% | 40 |
|
|
2022
Q2 | $1.04M | Buy |
5,853
+105
| +2% | +$18.7K | 0.58% | 37 |
|
|
2022
Q1 | $1.02M | Sell |
5,748
-206
| -3% | -$35.1K | 0.49% | 38 |
|
|
2021
Q4 | $1.02M | Sell |
5,954
-61
| -1% | -$9.99K | 0.49% | 40 |
|
|
2021
Q3 | $971K | Sell |
6,015
-492
| -8% | -$83.9K | 0.53% | 38 |
|
|
2021
Q2 | $1.07M | Sell |
6,507
-311
| -5% | -$51.5K | 0.6% | 36 |
|
|
2021
Q1 | $1.12M | Buy |
6,818
+583
| +9% | +$94.3K | 0.69% | 35 |
|
|
2020
Q4 | $981K | Buy |
6,235
+449
| +8% | +$66.3K | 0.61% | 36 |
|
|
2020
Q3 | $861K | Sell |
5,786
-17
| -0.3% | -$2.52K | 0.5% | 40 |
|
|
2020
Q2 | $816K | Buy |
5,803
+430
| +8% | +$62.7K | 0.47% | 44 |
|
|
2020
Q1 | $705K | Sell |
5,373
-191
| -3% | -$27.1K | 0.46% | 46 |
|
|
2019
Q4 | $720K | Buy |
5,564
+232
| +4% | +$31.5K | 0.39% | 48 |
|
|
2019
Q3 | $704K | Buy |
5,332
+2
| +0% | +$263 | 0.37% | 47 |
|
|
2019
Q2 | $742K | Hold |
5,330
| – | – | 0.4% | 45 |
|
|
2019
Q1 | $741K | Buy |
+5,330
| New | +$714K | 0.21% | 82 |
|
Other funds holding JNJ
Weaver Consulting Group's JNJ Position: Q2 2026 in Review
Weaver Consulting Group reduced its Johnson & Johnson (JNJ) stake by 0.71% in Q2 2026, selling an estimated $8.39K and leaving 5,013 shares worth $1.27M. The position accounts for 0.26% of the portfolio, ranked #81.
Weaver Consulting Group first reported a position in JNJ in Q1 2019 and has held it in 30 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Weaver Consulting Group held 5,013 shares of Johnson & Johnson worth $1.27M as of Q2 2026.
- Weaver Consulting Group sold 36 Johnson & Johnson shares in Q2 2026, an estimated $8.39K.
- Johnson & Johnson made up 0.26% of Weaver Consulting Group's portfolio in Q2 2026, its #81 holding.
- Weaver Consulting Group first reported a position in Johnson & Johnson in Q1 2019 and has held it in 30 quarters since.
- 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Weaver Consulting Group's 13F filing for Q2 2026, filed 29 Jul 2026.